Using Proton Pump Inhibitors is not Associated With Adverse Outcomes in Patients With Chronic Myeloid Leukemia Treated With Dasatinib

Fadi G. Haddad; Cedric Nasnas; Koji Sasaki; Shilpa Paul; Ghayas C. Issa; Caitlin Rausch; Elias Jabbour; Hagop Kantarjian

doi:10.1016/j.clml.2024.02.014

Using Proton Pump Inhibitors is not Associated With Adverse Outcomes in Patients With Chronic Myeloid Leukemia Treated With Dasatinib

Fadi G. Haddad, Cedric Nasnas, Koji Sasaki, Shilpa Paul, Ghayas C. Issa, Caitlin Rausch, Elias Jabbour, Hagop Kantarjian

Leukemia

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Journal	Clinical Lymphoma, Myeloma and Leukemia
DOIs	https://doi.org/10.1016/j.clml.2024.02.014
State	Accepted/In press - 2024

Keywords

Antacid
H2 blocker
Response
Tyrosine kinase inhibitor

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.1016/j.clml.2024.02.014

Cite this

@article{59e0f8488a844c229778fb98ebbc0050,

title = "Using Proton Pump Inhibitors is not Associated With Adverse Outcomes in Patients With Chronic Myeloid Leukemia Treated With Dasatinib",

keywords = "Antacid, H2 blocker, Response, Tyrosine kinase inhibitor",

author = "Haddad, {Fadi G.} and Cedric Nasnas and Koji Sasaki and Shilpa Paul and Issa, {Ghayas C.} and Caitlin Rausch and Elias Jabbour and Hagop Kantarjian",

year = "2024",

doi = "10.1016/j.clml.2024.02.014",

language = "English (US)",

journal = "Clinical Lymphoma, Myeloma and Leukemia",

issn = "2152-2650",

publisher = "Cancer Media Group",

}

TY - JOUR

T1 - Using Proton Pump Inhibitors is not Associated With Adverse Outcomes in Patients With Chronic Myeloid Leukemia Treated With Dasatinib

AU - Haddad, Fadi G.

AU - Nasnas, Cedric

AU - Sasaki, Koji

AU - Paul, Shilpa

AU - Issa, Ghayas C.

AU - Rausch, Caitlin

AU - Jabbour, Elias

AU - Kantarjian, Hagop

PY - 2024

Y1 - 2024

KW - Antacid

KW - H2 blocker

KW - Response

KW - Tyrosine kinase inhibitor

UR - http://www.scopus.com/inward/record.url?scp=85189105039&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85189105039&partnerID=8YFLogxK

U2 - 10.1016/j.clml.2024.02.014

DO - 10.1016/j.clml.2024.02.014

M3 - Letter

C2 - 38503634

AN - SCOPUS:85189105039

SN - 2152-2650

JO - Clinical Lymphoma, Myeloma and Leukemia

JF - Clinical Lymphoma, Myeloma and Leukemia

ER -

Using Proton Pump Inhibitors is not Associated With Adverse Outcomes in Patients With Chronic Myeloid Leukemia Treated With Dasatinib

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this